|Articles|November 24, 2009

Lab Network Improves PBMC Sample Quality to Support Clinical Trials - PPD Whitepaper

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

© iDoPixBox - © iDoPixBox - stock.adobe.com

Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation

ByAndy Studna, Senior Editor

June 25th 2026

Jonathan Andrus, CRIO, on Why Site-Sponsor Data Fragmentation Persists and What Central eSource Can Do About It

ByJonathan Andrus,Andy Studna, Senior Editor

June 25th 2026

ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion

ByAndy Studna, Senior Editor

June 25th 2026

2026 DIA Global Annual Meeting: On Leadership, Obesity, and the Science That's Redefining What's Possible

ByMarwan Fathallah,Andy Studna, Senior Editor

June 24th 2026

© photon_photo - © photon_photo - stock.adobe.com

Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract

ByRoger Joby, David Webber, and Simon Taylor

June 24th 2026

Lab Network Improves PBMC Sample Quality to Support Clinical Trials - PPD Whitepaper

Related Content

Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation

Jonathan Andrus, CRIO, on Why Site-Sponsor Data Fragmentation Persists and What Central eSource Can Do About It

ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion

2026 DIA Global Annual Meeting: On Leadership, Obesity, and the Science That's Redefining What's Possible

Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract

Trending on Applied Clinical Trials Online

Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract

Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025

Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation

HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research

ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion